JP2021530440A5 - - Google Patents
Info
- Publication number
- JP2021530440A5 JP2021530440A5 JP2020567854A JP2020567854A JP2021530440A5 JP 2021530440 A5 JP2021530440 A5 JP 2021530440A5 JP 2020567854 A JP2020567854 A JP 2020567854A JP 2020567854 A JP2020567854 A JP 2020567854A JP 2021530440 A5 JP2021530440 A5 JP 2021530440A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- oxavorinin
- benzo
- dihydro
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1809378.1A GB201809378D0 (en) | 2018-06-07 | 2018-06-07 | Novel compounds |
| GB1809378.1 | 2018-06-07 | ||
| PCT/EP2019/064599 WO2019234075A1 (en) | 2018-06-07 | 2019-06-05 | Novel benzimidamides compounds comprising an oxaborinin ring |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021530440A JP2021530440A (ja) | 2021-11-11 |
| JP2021530440A5 true JP2021530440A5 (enExample) | 2022-06-09 |
| JP7317866B2 JP7317866B2 (ja) | 2023-07-31 |
Family
ID=62975712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020567854A Active JP7317866B2 (ja) | 2018-06-07 | 2019-06-05 | オキサボリニン環を含む新規ベンズイミドアミド化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11352372B2 (enExample) |
| EP (1) | EP3802550B1 (enExample) |
| JP (1) | JP7317866B2 (enExample) |
| KR (1) | KR102661802B1 (enExample) |
| CN (2) | CN116217603A (enExample) |
| BR (1) | BR112020024740A2 (enExample) |
| ES (1) | ES2973710T3 (enExample) |
| GB (1) | GB201809378D0 (enExample) |
| WO (1) | WO2019234075A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200040103A1 (en) | 2018-03-14 | 2020-02-06 | Genentech, Inc. | Anti-klk5 antibodies and methods of use |
| GB201809378D0 (en) * | 2018-06-07 | 2018-07-25 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| AU2020349509A1 (en) | 2019-09-18 | 2022-03-31 | Genentech, Inc. | Anti-KLK7 antibodies, anti-KLK5 antibodies, multispecific anti-KLK5/KLK7 antibodies, and methods of use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2872962T3 (es) * | 2005-02-16 | 2021-11-03 | Anacor Pharmaceuticals Inc | Boronoftalidas para uso terapéutico |
| EP2225261B1 (en) * | 2007-12-03 | 2016-03-09 | Obe Therapy Biotechnology | Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism |
| EP3246034A1 (en) * | 2008-03-06 | 2017-11-22 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-inflammatory agents |
| DK3097085T3 (da) | 2014-01-23 | 2020-10-26 | Sixera Pharma Ab | Benzoxazinonderivater til behandling af hudsygdomme |
| SI3097084T1 (sl) | 2014-01-23 | 2021-01-29 | Sixera Pharma Ab | Novi zaviralci kalikreina 7 |
| GB201809378D0 (en) * | 2018-06-07 | 2018-07-25 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
-
2018
- 2018-06-07 GB GBGB1809378.1A patent/GB201809378D0/en not_active Ceased
-
2019
- 2019-06-05 JP JP2020567854A patent/JP7317866B2/ja active Active
- 2019-06-05 EP EP19729249.3A patent/EP3802550B1/en active Active
- 2019-06-05 US US16/972,732 patent/US11352372B2/en active Active
- 2019-06-05 ES ES19729249T patent/ES2973710T3/es active Active
- 2019-06-05 WO PCT/EP2019/064599 patent/WO2019234075A1/en not_active Ceased
- 2019-06-05 CN CN202310268678.7A patent/CN116217603A/zh active Pending
- 2019-06-05 CN CN201980037789.9A patent/CN112236433B/zh active Active
- 2019-06-05 KR KR1020217000497A patent/KR102661802B1/ko active Active
- 2019-06-05 BR BR112020024740-5A patent/BR112020024740A2/pt active IP Right Grant
-
2022
- 2022-05-06 US US17/738,097 patent/US11767333B2/en active Active